Table 6.

Preferences for Pre-Exposure Prophylaxis Modalities Across Classes

	Class 1: Shared decision-making		Class 2: Provider-led decision-making			Class 3: Patient-driven decision-making
	OR	aOR	OR	aOR	Class 1 versus 2 (p of interaction term in adjusted models)	OR	aOR	Class 1 versus 3 (p of interaction term in adjusted models)	Class 2 versus 3 (p of interaction term in adjusted models)
Daily oral PrEP	REF	REF	REF	REF	REF	REF	REF	REF	REF
bnAb	0.45***	0.41***	0.33***	0.29***	0.043*	0.36***	0.33**	0.14	0.44
Rectal douche	0.28***	0.22***	0.19***	0.14***	0.013*	0.25***	0.19***	0.39	0.07
PrEP implant	0.67***	0.67***	0.32***	0.31***	<0.0001***	0.46***	0.46*	0.01*	0.02*
Injectable PrEP	1.00	1.05	0.64***	0.66*	0.008**	0.83	0.86	0.20	0.10
Event-driven	1.00	0.96	0.67**	0.64**	0.015*	0.94	0.89	0.63	0.04*

Omnibus test for overall differences in preferences across classes: Wald χ²_(df=10) = 23.34, p < 0.01 (unadjusted model); Wald χ²_(df=10) = 22.17, p = 0.01 (adjusted models).

^* p < 0.05; ^**p < 0.01; ^***p < 0.001.

bnAb, broadly neutralizing antibodies.

Adjusted models control for age, race/ethnicity, and sexual identity.